Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
European Journal of Pediatrics
Erschienen in:

22.08.2018 | Original Article

Neonatal screening in the Czech Republic: increased prevalence of selected diseases in low birthweight neonates

verfasst von: Jan David, Petr Chrastina, Hana Vinohradska, Eva Al Taji, Andrea Holubova, Eva Hlidkova, Viktor Kozich, Felix Votava

Erschienen in: European Journal of Pediatrics | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Neonates with low birthweight (LBW) represent a vulnerable population. This retrospective study analyzed the birth frequency of diseases detected by neonatal screening (NBS) in normal and LBW neonates in the Czech Republic. Between years 2002 and 2016, the number of screened disorders in the Czech Republic gradually increased from two to 13. Prevalence of screened diseases was calculated for cohorts ranging from 777,100 to 1,277,283 neonates stratified by birthweight. Odds ratio of the association of LBW with each disease was calculated and statistical significance was evaluated using the chi-square test or Fisher’s exact test, as appropriate. Three diseases were associated with higher risk of prevalence in LBW neonates, namely congenital hypothyroidism (OR 2.50, CI 1.92; 3.25), cystic fibrosis (OR 2.44, CI 1.51; 3.94), and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) (OR 7.74, CI 2.18; 27.42).
Conclusion: Although the underlying mechanisms are not well understood, results can be hypothesized that LBW (respectively prematurity) may lead to the secondary and often transitory hypothyroidism while cystic fibrosis and LCHADD may manifest already prenatally and result into preterm birth and LBW.
What is Known:
• The percentage of low birthweight (LBW) neonates in the Czech Republic has been increasing.
• Previously published studies reported positive association between LBW and congenital hypothyroidism and cystic fibrosis.
What is New:
• The association between LCHADD and LBW has not yet been described.
• LBW can be the first manifestation of cystic fibrosis and LCHADD.
Literatur
1.
Cheong JL, Doyle LW (2012) Increasing rates of prematurity and epidemiology of late preterm birth. J Paediatr Child Health 48:784–788CrossRef
2.
Ananth CV, Vintzileos AM (2006) Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 19:773–782CrossRef
3.
Dalili S, Rezvany SM, Dadashi A, Medghalchi A, Mohammadi H, Dalili H, Mirzanejad M, Gholamnezhad H, Amirhakimi A (2012) Congenital hypothyroidism: a review of the risk factors. Acta Med Iran 50:735–739PubMed
4.
Waller DK, Anderson JL, Lorey F, Cunningham GC (2000) Risk factors for congenital hypothyroidism: an investigation of infant’s birth weight, ethnicity, and gender in California, 1990–1998. Teratology 62:36–41CrossRef
5.
Festini F, Taccetti G, Repetto T, Reali MF, Campana S, Mergni G, Marianelli L, de Martino M (2005) Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study. J Pediatr 147:316–320CrossRef
6.
Buyukgebiz A (2006) Newborn screening for congenital hypothyroidism. J Pediatr Endocrinol Metab 19:1291–1298PubMed
7.
Votava F, Novotna D, Kracmar P, Vinohradska H, Stahlova-Hrabincova E, Vrzalova Z, Neumann D, Malikova J, Lebl J, Matern D (2012) Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance. Eur J Pediatr 171:935–940CrossRef
8.
Sommerburg O, Krulisova V, Hammermann J, Lindner M, Stahl M, Muckenthaler M, Kohlmueller D, Happich M, Kulozik AE, Votava F, Balascakova M, Skalicka V, Stopsack M, Gahr M, Macek M Jr, Mall MA, Hoffmann GF (2014) Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations. J Cyst Fibros 13:15–23CrossRef
9.
Pourfarzam M, Zadhoush F (2013) Newborn screening for inherited metabolic disorders; news and views. J Res Med Sci 18:801–808PubMedCentral
10.
Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G (2014) European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 99:363–384CrossRef
11.
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC, Endocrine Society (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:4133–4160CrossRef
12.
Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW (2009) A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 8:71–78CrossRef
13.
Van Spronsen F, Mj van Wegberg A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gizewska M et al (2017) Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 5:743–756CrossRef
14.
Leonard JV, Dezateux C (2009) Newborn screening for medium chain acyl CoA dehydrogenase deficiency. Arch Dis Child 94:235–238CrossRef
15.
Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ (2014) A revised birth weight reference for the United States. Obstet Gynecol 124:16–22CrossRef
16.
Lee JH, Kim SW, Jeon GW, Sin JB (2015) Thyroid dysfunction in very low birth weight preterm infants. Korean J Pediatr 58:224–229CrossRef
17.
Bijarnia S, Wilcken B, Wiley VC (2011) Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. J Inherit Metab Dis 34:827–833CrossRef
18.
Gaudino R, Garel C, Czernichow P, Léger J (2005) Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol 62:444–448CrossRef
19.
Korzeniewski SJ, Grigorescu V, Kleyn M, Young WI, Birbeck G, Todem D, Romero R, Paneth N (2013) Transient hypothyroidism at 3-year follow-up among cases of congenital hypothyroidism detected by newborn screening. J Pediatr 162:177–182CrossRef
20.
Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT, Ellard S (2004) Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol 60:711–718CrossRef
21.
Tylek-Lemańska D, Kumorowicz-Kopiec M, Starzyk J (2005) Screening for congenital hypothyroidism: the value of retesting after four weeks in neonates with low and very low birth weight. J Med Screen 12:166–169CrossRef
22.
Cavarzere P, Camilot M, Popa FI, Lauriola S, Teofoli F, Gaudino R, Vincenzi M, Antoniazzi F (2016) Congenital hypothyroidism with delayed TSH elevation in low-birth-weight infants: incidence, diagnosis and management. Eur J Endocrinol 175:395–402CrossRef
23.
Muller AE, Thamm B, Lietz T, Handrick W, Walter S (1999) Cystic fibrosis: a cause of reduced birth weight? Eur J Pediatr 158:264CrossRef
24.
Mylona P, Glazier JD, Greenwood SL, Sides MK, Sibley CP (1996) Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol Hum Reprod 2:693–698CrossRef
25.
Strauss AW, Bennett MJ, Rinaldo P, Sims HF, O’Brien LK, Zhao Y, Gibson B, Ibdah J (1999) Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol 23:100–112CrossRef
26.
Deltetto N, Maxit C, Marchione D, Szlago M, Schenone A, Besada CH, Vaccarezza M, Agosta G (2012) Long chain 3-hydroxyacyl-coA dehydrogenase deficiency, association with HELLP and magnetic resonance spectroscopy findings. Arch Argent Pediatr 110:63–66CrossRef
27.
Karall D, Brunner-Krainz M, Kogelnig K, Konstantopoulou V, Maier EM, Möslinger D, Plecko B, Sperl W, Wolkmar B, Scholl-Burgi S (2015) Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD). Orphanet J Rare Dis 10:21CrossRef
28.
Anandi VS, Shaila B (2017) Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels. J Pediatr Endocrinol Metab 30:677–681CrossRef
Metadaten
Titel
Neonatal screening in the Czech Republic: increased prevalence of selected diseases in low birthweight neonates
verfasst von
Jan David
Petr Chrastina
Hana Vinohradska
Eva Al Taji
Andrea Holubova
Eva Hlidkova
Viktor Kozich
Felix Votava
Publikationsdatum
22.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 11/2018
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-018-3230-y

Weitere Artikel der Ausgabe 11/2018

Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty

  • Original Article

The associations between serum 25-hydroxyvitamin D and red blood cell indices reported from the KiGGS study are, except for mean corpuscular hemoglobin, not mediated by health-related quality of life

  • Correspondence

A review of feeding intolerance in critically ill children

  • Open Access
  • Original Article

Towards an individual screening strategy for first-degree relatives of celiac patients

  • Original Article

Pulmonary involvement in Niemann-Pick C type 1

  • Original Article

Elective cesarean delivery at term and the long-term risk for respiratory morbidity of the offspring

  • Original Article

Neu im Fachgebiet Pädiatrie

Bildschirmzeit und Myopie: Auf die Dosis kommt es an

  • 20.03.2025
  • Myopie
  • Nachrichten

Mit jeder zusätzlichen Stunde Bildschirmzeit pro Tag steigt das Risiko für Kurzsichtigkeit signifikant an – am stärksten bei Kindern zwischen zwei und sieben Jahren. Aber es könnte eine „sichere“ Nutzungsdauer geben.

Eosinophile Ösophagitis: Doppelte Dosis PPI wirkt besser

Protonenpumpenhemmer führen bei eosinophiler Ösophagitis nur in etwa jedem zweiten Fall zu einer klinischen bzw. histologischen Remission, so das Ergebnis einer Metaanalyse. Verbessern lässt sich die Quote möglicherweise mit einer Dosisverdopplung und der Aufteilung der Tagesdosis.

Mit Probiotika schneller fieberfrei?

Kinder mit fieberhaften Infektionen der oberen Atemwege profitieren möglicherweise von einer unterstützenden Behandlung mit Probiotika. Laut einer Studie aus Mailand steckt dahinter mehr als ein Placeboeffekt.

Hyperpronation beim „Kindermädchen-Ellenbogen“ wohl überlegen

Bei Kindern mit Radiusköpfchen-Subluxation ist die Hyperpronation wohl der klassischen Supinations-Flexionstechnik überlegen, möglicherweise auch im Hinblick auf Schmerzen. Darauf deuten die Ergebnisse einer aktuellen Metaanalyse hin.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise